-+ 0.00%
-+ 0.00%
-+ 0.00%

Piper Sandler Upgrades Claritev to Overweight, Raises Price Target to $44

Benzinga·05/29/2025 16:47:49
Listen to the news
Piper Sandler analyst Jessica Tassan upgrades Claritev (NYSE:CTEV) from Neutral to Overweight and raises the price target from $19 to $44.